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ABSTRACT
Objectives To evaluate the effect of four-phase national
lockdown from March 25 to May 31 in response to the
COVID-19 pandemic in India and unmask the state-wise
variations in terms of multiple public health metrics.
Design Cohort study (daily time series of case counts).
Setting Observational and population based.
Participants Confirmed COVID-19 cases nationally and
across 20 states that accounted for >99% of the current
cumulative case counts in India until 31 May 2020.
Exposure Lockdown (non-medical intervention).
Main outcomes and measures We illustrate the masking
of state-level trends and highlight the variations across
states by presenting evaluative evidence on some aspects
of the COVID-19 outbreak: case fatality rates, doubling
times of cases, effective reproduction numbers and the
scale of testing.
Results The estimated effective reproduction number
R for India was 3.36 (95% CI 3.03 to 3.71) on 24 March,
whereas the average of estimates from 25 May to 31
May stands at 1.27 (95% CI 1.26 to 1.28). Similarly, the
estimated doubling time across India was at 3.56 days on
24 March, and the past 7-day average for the same on
31 May is 14.37 days. The average daily number of tests
increased from 1717 (19–25 March) to 113 372 (25–31
May) while the test positivity rate increased from 2.1%
to 4.2%, respectively. However, various states exhibit
substantial departures from these national patterns.
Conclusions Patterns of change over lockdown periods
indicate the lockdown has been partly effective in
slowing the spread of the virus nationally. However, there
exist large state-level variations and identifying these
variations can help in both understanding the dynamics
of the pandemic and formulating effective public health
interventions. Our framework offers a holistic assessment
of the pandemic across Indian states and union territories
along with a set of interactive visualisation tools that are
daily updated at covind19.org.

INTRODUCTION
COVID-19 is an infectious disease caused by
SARS-CoV-2.1 First identified in December
2019 in Wuhan, China, it has since spread

Strengths and limitations of this study
►► Provides one of the first comprehensive nationwide

as well as state-level evaluation of the effect of national lockdown on progression of COVID-19 in India
using an ensemble of public health metrics.
►► Provides a set of public health metrics displayed via
interactive visualisation tools that are daily updated
at covind19.org to help inform dynamic policy towards containment and mitigation.
►► Introduces the concept of a cascade of ‘peaks’
across states instead of a solitary and unique national peak for the daily virus incidence curve.
►► Metrics presented in this study do not include predictions of future daily active cases nor account for
age-sex structure and mobility patterns and thus do
not inform us about projected healthcare needs.
►► Does not assess the degree of under-reporting in
cases and deaths and does not consider broader
and long-term impacts of the lockdown, for example, the economic and social costs.

globally, resulting in an ongoing pandemic.2
As of 9 June 2020, at the time of writing this
paper, more than 7 million cases have been
reported across 188 countries and territories, resulting in more than 405 000 deaths.
India, a democracy of 1.35 billion with a high
population density and fragile healthcare
infrastructure, is one of the global epicentres
for this pandemic. The first reported coronavirus infection in India was on 30 January
2020 and was identified as being imported by
travel. The government of India had initially
responded to the pandemic with closing
its borders and suspending all visas. With
the pandemic accelerating throughout the
world, the government began issuing advisories regarding social distancing measures
and eventually, India implemented a strict
nationwide lockdown from 25 March until
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governments responded to the pandemic with various
declarations of emergency, closure of institutions and
public meeting places, in addition to other restrictions to
contain the spread of the virus. Table 1 provides an overview of said variations over the four phases of lockdown in
India. As of 11 June, the number of total confirmed cases
in India has crossed 298 000, of whom 8501 have died and
146 972 have recovered, placing India at a worldwide rank
of 4 in terms of total confirmed cases.5 The number of new

Table 1 National and state-level lockdown measures implemented over the course of COVID-19 pandemic in India
Lockdown phase

Nationwide measures implemented

State-level variation in measures implemented

Phase 1
All transport services—road, air and rail—were
(25 March to 14 April) suspended, with exceptions for transportation
of essential goods, fire, police and emergency
services. Educational institutions, industrial
establishments and hospitality services were also
suspended.* Services such as food shops, banks
and ATMs, petrol pumps, other essentials and their
manufacturing were exempted.†
Phase 2
Conditional relaxation promised after 20 April,
(15 April to 3 May)
subject to containment of spread. Lockdown areas
classified into red, orange and green zones based
on extent of spread of disease. Certain relaxations
from 20 April: agricultural businesses, including
dairy, aquaculture and plantations allowed to open.
Cargo transportation vehicles allowed to operate.
Banks and government centres distributing
benefits allowed to open as well.§
Phase 3
(4–17 May)

Phase 4
(18–31 May)

Gujarat, Himachal Pradesh, Karnataka,
Maharashtra, Tamil Nadu, Sikkim and Telangana
sealed state borders. Additionally, Maharashtra,
Telangana and Tamil Nadu imposed Section 144,
outlawing large gatherings of people.‡

In interest of economic recovery, certain states
like Maharashtra chose to allow specific business
activities to resume, in addition to national easing
of restrictions. Karnataka chose to ease the
lockdown in certain areas, while Delhi, Punjab
and Telangana chose to enforce strict lockdown
measures.¶

Delhi allowed public and private-sector offices to
reopen, with social distancing measures in place.
Maharashtra eased most industrial and commercial
activities. Gujarat and Jharkhand allowed no
relaxation, while Bihar, Uttar Pradesh, Rajasthan
and Madhya Pradesh chose to mostly adhere to
guidelines issued by the Union Home Ministry.††
Unlike the previous phases, states were given a
Restricted individual movement allowed in Delhi,
larger say in the demarcation of green, orange and while Maharashtra, Tamil Nadu and Telangana
red zones and the implementation roadmap. Red extended the lockdown further. Karnataka allowed
zones were further divided into containment and
public transport with social distancing measures,
buffer zones. Local administrative bodies were
while West Bengal began easing workplace
given the authority to demarcate containment and restrictions. Stand-alone shops were allowed to
buffer zones.‡‡
open for short durations.§§
Zonal classification of regions into red, orange and
green zones continued, with normal movement
allowed in green zones. Movement of private and
hired vehicles allowed in orange zones and red
zones remained in lockdown. Zonal classifications
revised on a weekly basis.**

*Guidelines on measures to be undertaken by ministries/departments of government of India, state/union territory governments and state/
union territory authorities for containment of COVID-19 epidemic in the country (https://www.mha.gov.in/sites/default/files/Guidelines.pdf).
†The Economic Times: India’s 21-day lockdown to counter coronavirus: what’s exempt, what’s not, 25 March 2020 (https://economictimes.
indiatimes.com/news/politics-and-nation/india-21-day-lockdown-what-is-exempted-what-is-not/articleshow/74798725.cms).
‡Wikipedia: https://en.wikipedia.org/wiki/Indian_state_government_responses_to_the_COVID-19_pandemic.
§BBC: Coronavirus lockdown guidelines: what has India changed under new rules? 15 April 2020 (https://www.bbc.com/news/world-asiaindia-52290761).
¶Hindustan Times: Complete list of states with no relaxation in lockdown 2.0 restrictions, 20 April 2020 (https://www.hindustantimes.com/
india-news/complete-list-of-states-with-no-covid-19-lockdown-2-0-relaxation/story-pfE5K3Pn5LSZrgFEvC84hO.html).
**India Today: Full list of red, yellow, green zone districts for lockdown 3.0, 1 May 2020 (https://www.indiatoday.in/india/story/red-orangegreen-zones-full-current-update-list-districts-states-india-coronavirus-1673358-2020-05-01).
††Hindustan Times: COVID-19 lockdown 3.0: a look at relaxations, restrictions across major states in India, 4 May 2020 (https://www.
hindustantimes.com/india-news/coronavirus-update-covid-19-lockdown-3-0-a-look-at-relaxations-restrictions-across-major-states-in-india/
story-J5Z2IypwiagUTFf1wYW0jN.html).
‡‡The Economic Times: Lockdown 4.0 guidelines: nationwide lockdown extended until 31 May, with considerable relaxations, 21 May 2020
(https://economictimes.indiatimes.com/news/politics-and-nation/centre-extends-nationwide-lockdown-till-may-31-with-considerablerelaxations/articleshow/75790821.cms).
§§BBC: India lockdown 4.0: what is allowed in your city? 19 May 2020 (https://www.bbc.com/news/world-asia-india-52707371).
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31 May 2020,3 after which phased lockdown for containment zones is in effect until 30 June 2020.4 The government implemented a zonal classification of regions in the
nation, with each region falling in one of three classes—
red zones (hotspots with high doubling rates and high
number of active cases), orange zones (non-hotspots with
fewer cases) and green zones (regions without confirmed
cases or without new cases in the previous 21 days). In
addition to nationwide response patterns, Indian state

Open access

cases in India is not on the decline even after 9 weeks of
national lockdown. There is state-level variability in terms
of non-medical interventions and with respect to testing
patterns (both in terms of testing strategies as well as test
kits being used). The tests primarily used are the rapid
antigen tests and reverse transcription PCR (RT-
PCR)
tests, with the former being given priority in containment
zones and points of entry, while the latter are more widely
used in non-containment areas and hospital settings.6
In light of tremendous public health interest,
numerous data repositories, along with statistical models,
are being developed with the aim of studying the effect
of COVID-19 non-
medical interventions. The focus of
modelling is shifting from forecasting to evaluation of the
effect of various interventions on the spread of the virus.7
As of 9 June, 4880 COVID-19 SARS-CoV-2 preprints have
been uploaded to medRxiv and bioRxiv, of which at least
30 focus on analysing the efficacy of the non-medical
interventions implemented by the Indian government.
Ray and colleagues studied the short-term and long-term
impacts of the initial lockdown on the total number of
cases in India using standard epidemiological forecasting
models, and concluded that the lockdown stood a good
chance of reducing the total number of cases in India in
the short term.8 Looking at several metrics, Mitra and
colleagues suggested that curtailment strategies employed
by the Indian government seem to have been effective in
controlling the spread of the pandemic in the country.9
Ghosh and colleagues investigated the spread of the virus
Salvatore M, et al. BMJ Open 2020;10:e041778. doi:10.1136/bmjopen-2020-041778

and subsequent impact of preventive measures on the
same at a state level in India and noted that the lockdown
has had differential effects on daily infection rates for
various states in India.10 Jakhar and colleagues modelled
data released by the Indian Ministry of Health and Family
Welfare using the classical susceptible-infected-recovered
(SIR) model and calculated the basic reproduction
number (R0) for India as a whole, along with state-specific
values of the same.11 Similarly, Gupta estimated key epidemiological parameters and evaluated the effect of control
measures on the COVID-19 epidemic in India and its
states using a dynamic compartment-based susceptible-
exposed-infected-removed (SEIR) modelling approach,
reiterating that state-specific R0 values exhibit high variability with respect to the national value of R0.12 However,
much is left to be done now that the nationwide lockdown
has ended and a targeted lockdown phase is ongoing. All
epidemiological projections suggest that current gains
may be reversed rapidly if air travel and social mixing
resume. For the time being, the general guideline is to
reopen the country in a phased manner.13 The need of
the hour is to study and analyse infection, recovery and
fatality trends at a more granular level using multiple
measures of assessing epidemic dynamics to ensure the
formulation of targeted and customised interventions
aimed at containment and mitigation.
In this paper, we consider an ensemble of metrics including
case and death counts, case fatality rates (CFR), effective basic
reproduction numbers, doubling times (DT) and assessment
3
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Figure 1 Daily number of reported cases, fatalities and recovered cases in India (panel A) over the period between 15 March
and 31 May with four states to capture the variation. Kerala (panel B) was doing well initially but has seen a recent surge of
cases. Punjab (panel C) is an example state of ‘doing well’ whereas case counts in Maharashtra (panel D) and Delhi (panel E) are
still increasing.

Open access

a. Case-fatality rate (CFR1)

b. Doubling time
Assam
Uttarakhand
Bihar
Jharkhand
Karnataka
Kerala
Odisha
Haryana
Maharashtra
Delhi
West Bengal
Jammu and Kashmir
Tamil Nadu
Uttar Pradesh
Telangana
Rajasthan
Madhya Pradesh
Andhra Pradesh
Gujarat
Punjab
National estimate

Gujarat
West Bengal
Madhya Pradesh
Maharashtra
Telangana
Uttar Pradesh
Delhi
Rajasthan
Punjab
Andhra Pradesh
Karnataka
Jammu and Kashmir
Haryana
Tamil Nadu
Kerala
Jharkhand
Bihar
Uttarakhand
Odisha
Assam
National estimate
0.000

0.025

0.050

0.075

0

0.100

25

50

75

100

Doubling time (days)

CFR

Notes:
- 7-day average estimate with range shown.

c. Effective reproduction number

d. Test positivity rate

Assam
Uttarakhand
Haryana
Kerala
Telangana
Jharkhand
Jammu and Kashmir
West Bengal
Andhra Pradesh
Delhi
Karnataka
Bihar
Tamil Nadu
Maharashtra
Uttar Pradesh
Rajasthan
Odisha
Punjab
Madhya Pradesh
Gujarat
National estimate

Maharashtra
Delhi
Gujarat
Telangana
Madhya Pradesh
Tamil Nadu
Bihar
Punjab
Uttar Pradesh
West Bengal
Rajasthan
Uttarakhand
Kerala
Haryana
Jammu and Kashmir
Odisha
Karnataka
Assam
Jharkhand
Andhra Pradesh
National estimate
0

1

2

3

R

0.00

0.05

0.10

Test positivity rate

Notes:
- 7-day average estimate with 95% confidence interval shown.

© COV-IND-19 Study Group
Source: covid19india.org (data through May 31)

Figure 2 Forest plot dashboard. (A) Forest plot of estimated case fatality rates (CFR1) based on all confirmed cases as of
31 May, along with 95% CIs, for 20 states and union territories of India, and a national summary.(B) Forest plot of estimated
doubling times (in days) based on data from a 7-day past window from 31 May, along with 95% CIs, for 20 states and union
territories of India, and a national summary. (C) Forest plot of estimated time-varying R (effective basic reproduction number)
based on data from a 7-day past window from 31 May, along with 95% CIs, for 20 states and union territories of India, and a
national summary. (D) Forest plot of test positivity rates (proportion scale) based on data as of 31 May, for 20 states and union
territories of India, along with a national summary.

of testing across states for a deeper and policy-
relevant
understanding of the COVID-19 situation in India after four
contiguous periods of lockdown from 25 March to 31 May
(lockdown 1.0: 25 March to 14 April,14 lockdown 2.0: 15 April
to 3 May,15 lockdown 3.0: 4 May to 17 May,16 lockdown 4.0:
18 May to 31 May17). By studying the series of natural experiments across the states and learning from their successes and
failures, one has a better likelihood of designing improved
targeted interventions for the next phase of the pandemic.
Our proposed comprehensive dashboard has broader utility
for policymakers and the supporting interactive platform
presents daily updates for all metrics and models.

METHODS
We use publicly available data for all our analyses (covid19india.org and Our World In Data).5 18 All source code
and interactive plots are available at c ovind19.org.19 All
computations were done using the RStudio platform.
Case and death counts and fatality rates
In addition to simple case and death counts, we look at CFRs
estimated using all confirmed cases (CFR1, ratio of the total
number of deaths and the total number of cases) and closed
cases only (CFR2, ratio of the total number of deaths and
the sum of the same and the total number of recovered
cases). We construct appropriate CIs for these measures.20
DTs and growth rates/reproduction number
To quantify the growth of the pandemic, we estimated DTs
for total confirmed cases using a 7-day backward-looking

4
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COVID-19 in India Dashboard
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window. This measure gives the number of days it would
take for total cases to double if its trajectory remained
as observed in the past week, and an increase in the
DT is evidence of the pandemic slowing down. We use
a descriptive measure as well as fit a log-linear model to
estimate the DT (see online supplemental material). We
also use a Bayesian sequential method to estimate the
time-
varying effective basic reproduction number, R, which
measures the average number of persons infected by an
infected individual. When R falls below 1, the epidemic
starts slowing down.21 The estimation of the time-varying
R is performed using the EpiEstim package in R and daily
case count data from COVID-19 India.5 21 In particular, we
used the vectors of daily new cases as our input using the
‘parametric_SI’ estimation method and a 5-day window
(‘estimate_R’ function, which was used to describe the
progression of the outbreak in Wuhan).22 We also use a
Salvatore M, et al. BMJ Open 2020;10:e041778. doi:10.1136/bmjopen-2020-041778

gamma distribution prior with a mean of 7 days and an
SD of 4.5 days, based on research by Wu and colleagues,
for the generation time (a distribution of the onset of
disease used to estimate R).23
Testing summaries
In order to understand the testing landscape, we compute
the proportion of population tested, test positivity rates
(TPRs) and quantify testing metrics (number of tests, TPR,
percentage of population tested) at the national and state
levels. We also introduce a metric of testing shortfall which
can be used after lockdown during the state of control of a
pandemic to ensure sustained control of the TPR at a target
level (eg, in May WHO recommended this target to be set at
5%24). This may be useful for India after the daily incidence
curve turns the corner which unfortunately did not happen
during our study period of lockdown.
5
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Figure 3 National estimates of doubling times and time-varying R. (A) Estimated doubling times of total number of COVID-19
cases in India, with averages for the prelockdown and postlockdown periods and past 7-day average as of 31 May. (B)
Estimated time-varying R (effective basic reproduction number) for COVID-19 in India with averages for the prelockdown and
postlockdown periods and past 7-day average as of 31 May, along with 95% CIs.

Open access

The detailed definition of each reported metric and
methods for computing corresponding measures of
uncertainty are presented in the online supplemental
methods. All our analyses use data available from 15
March until 31 March, 31 March being the day India’s
strict national lockdowns ended and ‘unlocking’ started.
Patient and public involvement
No patient involvement.
RESULTS
Total number of cases and deaths
India had reported its first case of COVID-19 on 30 January.
The first death from COVID-19 was reported on 12 March.
In the second week of May, India recorded the highest
growth in case counts among Asian countries.19 As of 9
June, only four countries (USA, Brazil, Russia and UK) had
recorded more cases than India.25 Online supplemental
6

figure 1 presents national trends of the COVID-19 outbreak
in India by plotting the cumulative number of confirmed
cases, fatalities and recovered cases. To highlight the
pronounced geographic pattern across states not visible in
online supplemental figure 1, figure 1 compares the daily
profile of the pandemic at the national level with four states:
two that are doing well (Kerala and Punjab) and two that
have been hit hard (Maharashtra and Delhi) in terms of the
same three counts. It is clear that Punjab has been doing
well and has experienced the first initial peak, Kerala seems
to have many new cases after the strong initial control, Maharashtra has an increasing trend that seems to be stabilising
while Delhi has a high number of cases with a sudden jump
in case counts near the end of the nationwide lockdown.
Since Maharashtra contributes nearly 35%–40% of India’s
total number of cases, the national pattern has more resemblance to Maharashtra. Two crucial points emerge from the
geographic pattern. First, the concentration of the case load
Salvatore M, et al. BMJ Open 2020;10:e041778. doi:10.1136/bmjopen-2020-041778
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Figure 4 State-wise estimates of doubling times and time-varying R. (A) Estimated doubling times of total number of
COVID-19 cases in 20 Indian states and union territories. (B) Estimated time-varying R (effective basic reproduction number) for
COVID-19 in 20 Indian states and union territories along with 95% CIs.

Open access

Case fatality rates
Figure 2A (CFR1) and online supplemental figure 4 (CFR2)
present forest plots of the two estimates of the CFR, along
with 95% CIs, for the 20 states/union territories and for
the nation as a whole. Using CFR1, there are several states
with CFR1 above 3%: Gujarat (6.2%), West Bengal (5.8%),
Madhya Pradesh (4.3%) Maharashtra (3.4%) and Telangana (3.0%). Similarly, the same five states plus Delhi have
elevated CFR2 estimates (above 6%).
DT and reproduction number
Figure 3A plots the estimated DTs and figure 3B plots the
estimated time-varying R nationally. Since reliable estimates of DT and R require many days of data, figure 3A,B
starts on 15 March. In both, we report the estimate (along
with the 95% CIs for R) on 24 March, 14 April, 3 May and
18 May corresponding to the initial lockdown and subsequent extensions, in order.
The time series patterns of estimated DT and R nationally
show that the lockdown did slow down the spread of the
pandemic. It took about 2 weeks for the DT to start moving
up in a sustained manner. Since early April, the DT has
increased from about 5 to over 14 days by the end of May
(figure 3A). Turning to figure 3B, we see that the estimated
value of R fell over the first lockdown from 3.36 (95% CI
3.03 to 3.71) on 24 March to 1.71 (95% CI 1.66 to 1.76) on
14 April, with substantial fluctuation in between. Since then,
the estimated R has fallen at a slower pace. The trailing 7-day
average value of R for the week ending on 31 May is 1.27
(95% CI 1.26 to 1.28).
level
These national patterns hide substantial state-
variations, observable in state level (figure 4A (DT) and

figure 4B (R)). Figure 4A shows that estimated DTs have
mostly increased, with Assam, Delhi, Haryana, Odisha
and Uttarakhand being some noteworthy exceptions.
Figure 4B indicates that starting from higher values, estimates of R have generally fallen across all states. Again,
there are significant differences across states—some
states continue to have high values (eg, Maharashtra),
and some others, after a period of low estimates of R, have
reverted to relatively high value (eg, Kerala).
Figure 2B,C presents forest plots of the average value of
the DT (with 7-day range) and estimated R (with 95% CI)
over the week before 31 May, respectively. Only two states
have estimated R below 1 (Madhya Pradesh and Gujarat)
and four states have estimated R over 2 (Assam, Uttarakhand, Haryana and Kerala).
Testing coverage and TPR
Going by national-level data, India seems to be doing fairly
well in terms of TPRs. Since mid-April, India’s TPR has
fluctuated around 0.04 (figure 5). This is lower than many
European and North American countries at that time,
and significantly lower than its neighbours, like Bangladesh and Pakistan.8 26 But this national trend hides the
wide variation across states. Online supplemental figure
5 plots the TPR over time for our sample of 20 states/
union territories, exhibiting obvious and striking state-
wide variations (with recent estimates being summarised
in figure 2D). Rising TPR is noted in most of these states
where the pandemic is geographically concentrated.
Important examples are Delhi, Gujarat, Maharashtra
and Tamil Nadu, which have both high case counts and
high/rising TPRs. Bihar, Telangana and Uttarakhand,
with relatively low case counts so far, are witnessing rising
TPRs, as seen in table 2, which also contains the proportion of population tested by 31 May across each state
(online supplemental table 1 is an updated version of this
table with data through 15 September to have the latest
assessment).

COVID-19 test positivity rate in India
as of May 31

Test positivity rate

0.045

0.040

Last 7-day average:
4.15%

0.035

0.030
Apr 01

Apr 15

May 01

May 15

Jun 01

Date
© COV-IND-19 Study Group
Source: covid19india.org

Figure 5

Time series plot of test positivity rates for India over the period between 1 April and 31 May.
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among the top 10 states has remained relatively stable, at
around 90% of the national case count, over this 2-month
period. Second, the membership of the top 10 states has
changed gradually—even as Maharashtra, Delhi and Uttar
Pradesh have continued to figure in the list at all four lockdown markers. Online supplemental figures 2 and 3 plot
cumulative case and death counts, respectively, across states
and over time to highlight these geographic patterns.

Open access

Metrics
Location

R

Doubling time (days)

CFR

Test positivity rate Total tested Population

PPT (%)

National estimate
Maharashtra

1.27
1.18

14.4
13.8

0.028
0.034

0.042
0.136

3 737 027
463 177

1 332 830 000
122 153 000

0.28
0.38

Delhi

1.46

14.2

0.024

0.086

212 784

19 814 000

1.07

Gujarat

0.93

25.6

0.062

0.079

211 930

67 936 000

0.31

Tamil Nadu

1.19

14.6

0.008

0.044

491 962

75 695 000

0.65

Madhya Pradesh

0.99

21.5

0.043

0.049

167 808

82 232 000

0.2

Bihar

1.19

9.9

0.006

0.044

75 737

119 520 000

0.06

Uttar Pradesh

1.12

17.4

0.027

0.028

289 892

224 979 000

0.13

West Bengal

1.56

14.2

0.058

0.026

203 751

96 906 000

0.21

Rajasthan

1.11

19.1

0.022

0.022

409 777

77 264 000

0.53

Punjab

1.07

73.5

0.020

0.029

87 852

29 859 000

0.29

Uttarakhand

3.14

3.9

0.006

0.021

30 438

11 141 000

0.27

Andhra Pradesh

1.54

23.3

0.017

0.008

372 748

52 221 000

0.71

Assam

3.18

3.5

0.002

0.009

109 097

34 293 000

0.32

Haryana

2.23

12.8

0.010

0.015

118 138

28 672 000

0.41

Jharkhand

1.59

10.1

0.008

0.008

65 886

37 403 000

0.18

Jammu and Kashmir 1.58

14.5

0.011

0.013

171 045

13 203 000

1.3

Karnataka

1.43

10.4

0.016

0.010

293 575

65 798 000

0.45

Kerala

2.04

11.8

0.008

0.015

77 508

35 125 000

0.22

Odisha
Telangana

1.09
1.85

12.0
18.2

0.005
0.030

0.012
NA

152 131
NA

43 671 000
37 220 000

0.35
NA

CFR, case fatality rate; NA, not applicable; PPT, proportion of population tested.

Summary state-level dashboard: comprehensive display of
metrics
With a complete data tsunami, different metrics telling us
different features of the pandemic and a rapidly evolving
landscape, we offer a summary dashboard (figure 2) for
the states and the nation according to various metrics.
This captures a snapshot of where things stand across
states and the nation, with daily updates available in our
app hosted at covind19.org.19
Figure 2A shows CFR1 along with the 95% CI. While
the all-India CFR1 on 31 May was 2.84%, state-level CFR1s
ranged from 6.2% (Gujarat) to 0.2% (Assam). Figure 2B
shows the 7-day average DT along with the range. The
quickest DT is in Assam (3.5 days, range: 3.1, 4.0) while
the slowest DT is in Punjab (73.5 days, range: 51.6, 97.5).
The national estimate is 14.4 days (range: 13.2, 15.2),
with about half of states having DT exceeding 14 days.
Figure 2C shows the 7-day average R along with the
95% CIs. We see that 7-
day average estimates range
from 0.93 (95% CI 0.89 to 0.97) in Gujarat to 3.17 (95%
CI 2.91 to 3.45) in Assam, with a national estimate of
1.27 (95% CI 1.26 to 1.28). Figure 2B,C exhibits how
the DT, a function of cumulative cases, is less sensitive
to daily movements than R. For example, Kerala has
done well controlling the outbreak in terms of DT, but
8

a small recent increase in observed cases results in a
7-day average R estimate close to 2.
Figure 2D shows the 7-day average TPR along with the
range. The lowest 7-day average TPR is seen in Andhra
Pradesh (0.83%, range: 0.81%, 0.85%), with the highest
being seen in Maharashtra (13.63%, range: 13.25%,
14.07%). Generally, states with larger cumulative case
counts are seen to have higher TPRs. A high TPR most
likely indicates inadequate levels of testing relative to
the size of the outbreak. Thus, states with large number
of reported cases are also likely to be suffering from
low testing relative to the size of the outbreak in these
states. The national 7-day average TPR is 4.15% (range:
4.03%, 4.26%).
It is important to consider these metrics together,
keeping their nuances in mind:
►► CFR1 is an indicator of the fatality associated with the
epidemic, but its value is sensitive to the number of
tests being performed. A high CFR1 might very well
arise from inadequate testing. Hence, the CFR1 is best
used in conjunction with some measure of adequate
testing.
►► R can indicate a recent outbreak but is sensitive to the
level of daily cases being observed (ie, a state/union
territory with few cases can have a high R). In parallel,
Salvatore M, et al. BMJ Open 2020;10:e041778. doi:10.1136/bmjopen-2020-041778
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Table 2 COVID-19 metrics table for India and the 20 states with the most cumulative case counts as of 31 May 2020
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DISCUSSION
While it is common for analysts and policymakers to
predict a peak for the COVID-19 in India,27 28 our analysis shows that the concept of a peak for the whole
country is, at best, ambiguous. Differences in estimates
of R (figure 4B) and estimated DTs (figure 4A) suggest
that peaks will vary across states. Predictions from the
extended SIR (eSIR)8 29 model available at covind19.org
show that peak in case counts might start as early as the
end of July in some states and go all the way to October
in many others. (For a description of the method and the
parameter settings used for the prediction models, please
refer to the online supplemental methods and accompanying online supplemental figures 6 and 7.) Some states
like Punjab have already experienced their first peak.
These predictions are in line with basic intuition about
the dynamics of the pandemic in India. Initial cases were
imported, and the initial growth was limited to a few states
which saw the arrival of international travellers. These
initial cases seeded the epidemic and saw the explosion
of cases. With the non-medical intervention of lockdown,
mobility was limited at the macro level (interstate, intercity), which reduced transmission rates (figures 3 and 4).
Prelockdown infections and micromobility resulted in
growth of cases within states; notably, the top 10 states on
18 April and 31 May are largely the same. Now that we are
in the targeted lockdown phase, internal migration will
start playing an increasingly important role in the spread
of the pandemic.
India has a large migrant worker population. Estimates
of out-of-state and out-of-district migrants ranged from
60 to 80 million in 2011, and average work-related migration flows between states over the period 2011–2016 were
about 9 million per year.30 With the easing of lockdown
and work slowly resuming, a large migrant population will
soon start travelling back to their workplaces and India
could see the next surge in cases in states home to higher
numbers of migrant workers. At the time of writing this
paper in June this was our prediction. Indeed, at the time
of revising the paper, we created pie charts in online
supplemental figure 8 which show the shift in contributions of cases by state over time (through 15 September)
which support our previous conjecture. Additional
references on COVID-19 models incorporating migration and mobility can be found in online supplemental
table 2.31–35 A combined and rigorous strategy of testing
Salvatore M, et al. BMJ Open 2020;10:e041778. doi:10.1136/bmjopen-2020-041778

suspected patients, tracing contacts of patients and
isolating infected persons can effectively break the chain
of transmission and slow down the pandemic. Intensifying government messages on social distancing, mask
wearing, avoiding large indoor gatherings and hygiene
can allow the country to reopen safely. In a country like
India, which can ill afford the severe economic disruption
caused by a lockdown, this alternative approach has much
to recommend itself.36
Regarding testing, the most common approach is to
track the TPR, that is, fraction of positives in the total
number of persons tested.37 High and/or rising TPRs
indicate that either community prevalence is truly rising
or that the level of testing is inadequate relative to the
size of the outbreak so only symptomatic cases are being
tested. Steady decline in TPR to 5% or less for at least 14
consecutive days may indicate the pandemic is in a control
phase,24 that is, an indication that effective R is declining
and less than 1. The testing shortfall metric can then be
gainfully employed to determine the number of tests that
need to be done randomly in the community for surveillance during a control phase. In order to devise a testing
strategy, it is important not just to think about the number
of tests but consider various types of tests, including rapid
antigen test, RT-PCR test and cost-efficient testing strategies such as pooled testing, stratified periodic sampling to
capture asymptomatic individuals. The goal of testing be it
for clinical diagnostic purpose, screening or surveillance
should be clear. The testing shortfall metric may indicate
that we need to carry out a large number of tests that we
do not have resources for, but this number can inform us
when and where to scale up syndromic surveillance using
community and government healthcare workers.
The estimated prevalence of the disease by TPR will
usually be an overestimate of the ‘true’ prevalence rate
due to testing of the symptomatic individuals who are
more likely to have an active infection. On the other
hand, under-reporting of silent or covert infections and
lack of testing of mildly symptomatic individuals is a major
challenge in estimating the true prevalence and infection fatality rate (IFR). The extent of under-reporting in
terms of the number of confirmed cases and deaths is a
pertinent metric in this context, and the under-reporting
factor possibly varies across the states. Although we did
not attempt to estimate the under-
reporting factor in
this paper, largely because our predictions come from an
eSIR model that does not naturally model the asymptomatic infections and hence does not provide estimates of
the true unreported number of cases, there exist modifications of such model-based approaches providing an
estimate of the covert infections. An SEIR model applied
to data from Wuhan, China, has earlier provided estimates of the under-reporting factor in terms of cases and
deaths.38 In one of our recent works, we extended this
SEIR model to account for misclassifications due to imperfect diagnostic testing and computed revised estimates
of the under-reporting factor for cases and deaths using
data from Delhi, the national capital region of India.39
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►►

DT is a longer term measure since it is a function of
cumulative cases (ie, this metric is more robust to
fluctuations in recent daily cases). These are relative
metrics and do not inform us about projected healthcare needs.
TPR is both a function of the size of the outbreak in
an area and the number of tests being performed. A
higher TPR can indicate insufficient levels of testing
and selective testing of symptomatic patients but also
a good predictor of an emerging outbreak when large
numbers of tests are done.
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age-sex structure and mobility patterns in India. A full
spatiotemporal model with more granular data is in
order. Third, the quality of the data is in question with
the existence of evidence that reported case counts
are significantly lower than true case counts. However,
this data set is the most comprehensive and regularly
updated data set on COVID-19 in India and the undercount is likely missing asymptomatic cases rather than
symptomatic cases. Attempting to correct for misclassification and other data errors is beyond the scope of
this paper. Finally, we consider a narrow evaluation of
the lockdown in terms of COVID-19-related outcomes
using data up to 31 May. There are many long-term
and broader consequences of the lockdown that this
paper fails to capture.
The success of some states gives us hope that there are
strategies to beat this insidious virus that have worked
in a low-resource setting. Resources can be mobilised
and optimally deployed to address the acute situations
in high-
density population areas like Maharashtra,
Gujarat and Delhi. In all these efforts, nuanced state-
level summaries offer their utility to inform national
policies.
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We also performed validation for these model-based estimates using estimated seroprevalence information from
a serosurvey performed in the region.40 Another recent
study has used a multicountry-modified SEIR model to
estimate COVID-19 under-reporting across 86 countries
and has reported significant variability between the countries in terms of the estimated under-reporting factor.41
The effect of under-reporting of cases and deaths on IFRs
can be found in online supplemental table 3. Depending
on the degree of under-reporting for cases and deaths,
the IFR ranges from 0.1% to 1.0%. One has to remember
that even with a low IFR of around 0.1%, if 50% of people
in India get infected, the nation will incur 670 000 deaths.
Given the spatial and temporal pattern of the pandemic’s spread, it is extremely important to prioritise policies.
Resources must be mobilised to help one cluster of states
and then move to the next cluster. It might be useful for
the central government and the Indian Council of Medical
Research to classify states in terms of the phases of the
epidemic. Even as the worst-hit states are being addressed,
the next set could be put on high alert. It is this dynamic
policy intervention that will be required to deal effectively
with the cascading pattern of the pandemic across Indian
states (refer to table 2 to see state-level variation).
In implementing such a dynamic policy, it is extremely
important to facilitate replication of successful strategies
across states. Kerala’s rapid response in terms of testing,
contact tracing and quarantining; Odisha and Kerala’s
use of local governance structures and community health
networks for surveillance and dissemination of correct
information; Punjab’s use of data analytics and district-
level granular contact tracing, tracking and isolation—all
these experiences will be of use in other states that are
likely to see a surge in cases in the coming weeks.
There are several strengths of this work. First, it provides
a comprehensive nationwide as well as state-level evaluation of the effect of India’s national lockdown (Ghosh
et al10 is another notable state-level analysis but focuses
on forecasting rather than retrospective evaluation)
on COVID-19 outbreak in India using an ensemble of
metrics. These metrics can aid policymakers to track and
assess the spread of the outbreak and identify areas where
interventions may play an important mitigating role.
Second, these metrics are publicly available and displayed
via interactive visualisation tools that are daily updated
at covind19.org19 to help inform dynamic policymaking
and intervention towards containment and mitigation.
Third, our state-level analysis highlights heterogeneity of
outbreak progression across India and the concept of a
cascade of ‘peaks’ across states instead of a solitary and
unique national peak for the daily virus incidence curve.
There are also some limitations to this work. First,
the metrics presented do not include predictions of
future daily active cases and thus do not inform us
about projected healthcare needs. We also refrain
from predicting fatalities. The nature of this paper
is more of retrospective evaluation than prospective
forecasting. Second, our methods do not account for
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